文献速递免疫规划卫生政策与健康促进

2002-2015年韩国人乳头瘤病毒感染相关疾病的经济负担

The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015.
PubMed 文献 · Vaccine · 2018-06-28

这项基于患病率的疾病成本研究利用韩国国民健康保险服务理赔数据,估算2016年启动12岁女孩HPV疫苗常规接种前HPV相关疾病的患病率与直接医疗费用。作者认为扩大女孩HPV疫苗接种年龄目标并引入男孩接种是可考虑减轻经济负担的途径。

核心结论

  • 韩国HPV相关疾病的医疗费用可观,2002-2015年间增加,主要因患者数增加。
  • 作者认为扩大女孩HPV疫苗接种年龄目标并引入男孩接种是可考虑减轻HPV相关疾病经济负担的途径,应予以考虑。

研究设计与样本

  • 基于患病率的疾病成本研究,使用韩国国民健康保险服务提供的理赔数据估算HPV相关疾病的患病率及直接医疗费用(含住院、门诊和药物费用)。
  • 研究时段为2002-2015年,处于2016年启动12岁女孩HPV疫苗常规接种之前。

主要发现

  • 女性中最常见的HPV归因疾病为宫颈异型增生(64.4%)、肛门生殖器疣(12.9%)、宫颈原位癌(10.7%)和宫颈癌(2.6%)。
  • 男性中最常见的为肛门生殖器疣(80.6%)、喉良性肿瘤(14.3%)和肛门癌(8.9%)。

临床怎么用

  • 作者认为扩大女孩HPV疫苗接种年龄目标并引入男孩HPV疫苗接种是可考虑减轻HPV相关疾病经济负担的途径,应予以考虑。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This prevalence-based, cost-of-illness study estimated the health care costs of human papillomavirus (HPV) infection-associated diseases in the era before the introduction of organized HPV vaccination for 12-year-old girls in 2016, South Korea. METHODS: The claims data provided by the National Health Insurance Service was used to estimate the prevalence of HPV-associated diseases and their direct medical costs, including costs related to hospitalizations, outpatient visits, and medications. RESULTS: A total of 1.3 million men and women used medical services for HPV-attributed diseases between 2002 and 2015. Among women, the most common diseases attributable to HPV were cervical dysplasia (64.4%), anogenital warts (12.9%), cervical carcinoma in situ (10.7%) and cervical cancer (2.6%), whereas anogenital warts (80.6%), benign neoplasms of larynx (14.3%), and anal cancers (8.9%) were most common among men. In 2015, the healthcare cost attributable to HPV was 124.9 million US dollars (USD) representing 69.0% of the annual cost of all HPV-associated diseases. At a cost of 75.1 million USD, cervical cancer contributed the largest economic burden in 2015 followed by cervical dysplasia (19.4 million USD) and cervical carcinoma in situ (10.7 million USD). These three conditions represented 58.2% of the total annual cost of all HPV-associated diseases, while 84.2% of the total annual cost was attributable to HPV. Annual health care costs increased from 42.6 million USD in 2002 to 180.9 million USD in 2015. CONCLUSION: The healthcare costs associated with HPV-related diseases in Korea are substantial and increased between 2002 and 2015 mainly caused by increased number of patients. Expanding the target age for HPV vaccination of girls and introducing HPV vaccination for boys are possible ways of reducing the economic burden of HPV-associated disease and should be considered.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ki M, Choi HY, Han M, et al. The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015. Vaccine. 2018. PMID: 29961603. doi:10.1016/j.vaccine.2018.06.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。